Chinatsu Sakata-Sakurai
Company: Astellas Pharma
Job title: Vice-President, Primary Focus Lead, Targeted Protein Degradation
Seminars:
ROUNDTABLE DISCUSSION: Utilizing Pre-Clinical Data to Predict the Right Dosing Regimen for Your TPD Drug 1:30 pm
day: Day 2, Track 2, PM
Targeting ‘Undruggable’ Targets: Pioneering Novel Applications of Heterobifunctional Degrade 9:30 am
day: Day 1 - Until 10:15